Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient
功能性同源重组 (HR) 筛选表明，大多数 BRCA1/2 突变型乳腺癌和卵巢癌细胞系均具有 HR 功能
期刊:Cancers
影响因子:
doi:10.3390/cancers16040741
Titia G Meijer, John W M Martens, Wendy J C Prager-van der Smissen, Nicole S Verkaik, Corine M Beaufort, Stanley van Herk, Teresa Robert-Finestra, Remco M Hoogenboezem, Kirsten Ruigrok-Ritstier, Maarten W Paul, Joost Gribnau, Eric M J Bindels, Roland Kanaar, Agnes Jager, Dik C van Gent, Antoinette H
